Head of Regulatory affairs and Quality assurance, MSc
Regulatory and compliance
Jennie brings a broad experience from regulatory work within the life science and medical devices industry at PlantVision AB and St. Jude Medical, where she has worked with vigilance, CE marking, global submissions, regulatory strategy, and held courses/seminar in the Medical Device Regulations (MDR, IVDR).
”It feels both important and intriguing to contribute to Stratipaths mission. Getting innovative research into practical use safely is what regulatory work is all about. I am looking forward to working closely with the product development and medical affairs teams to make sure we reach compliance for CE marking for our products.“ Says Jennie.
“In addition to Jennie's excellence and long experience in the field, we also appreciate her drive and personality, which we believe will be crucial in achieving our mission to improve cancer treatment decisions and patient outcomes.” Says CEO Fredrik Wetterhall
Stratipath brings together physicians, researchers, AI-scientists, developers and industry specialists with its aim to help all patients get the right treatment through precision diagnostics. Stratipath is a spin-out from Karolinska Institutet in Stockholm, Sweden, bringing pioneering research from the fields of AI and precision medicine into clinical use. The company was founded in 2019 with a mission to radically improve cancer treatment decisions and patient outcomes. Stratipath uses AI technology and research to improve cancer diagnostics for more patients. Today far too many patients receive inconclusive cancer diagnoses and have unequal access to precision diagnostics. Stratipath’s AI technology can change this by providing patients with faster access to novel, more conclusive and precise results, at a sustainable cost.
Already working at Stratipath AB?
Let’s recruit together and find your next colleague.